These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 8978934)
1. Role of different subtypes of adrenoceptors in pressor responses to catecholamines released from sympathetic nerve endings. Dóda M Brain Res Bull; 1997; 42(1):51-7. PubMed ID: 8978934 [TBL] [Abstract][Full Text] [Related]
2. Effect of CH-38083, a selective antagonist of alpha 2-adrenoceptors, on renal sympathetic function. Dóda M; Vizi ES Neuropharmacology; 1989 Feb; 28(2):135-40. PubMed ID: 2566132 [TBL] [Abstract][Full Text] [Related]
3. Sympathetic neurotransmission in the rat testicular capsule: functional characterization and identification of mRNA encoding alpha1-adrenoceptor subtypes. Jurkiewicz NH; Caricati-Neto A; Verde LF; Avellar MC; Reuter HR; Jurkiewicz A Eur J Pharmacol; 2006 Aug; 543(1-3):141-50. PubMed ID: 16822496 [TBL] [Abstract][Full Text] [Related]
4. DMPP-evoked increases in postganglionic sympathetic nerve activity and blood pressure occurs by two mechanisms in the rat. Martin JR J Auton Pharmacol; 1997 Aug; 17(4):249-59. PubMed ID: 9373784 [TBL] [Abstract][Full Text] [Related]
5. Effect of dexmedetomidine on the release of [3H]-noradrenaline from rat kidney cortex slices: characterization of alpha2-adrenoceptor. Taoda M; Adachi YU; Uchihashi Y; Watanabe K; Satoh T; Vizi ES Neurochem Int; 2001 Apr; 38(4):317-22. PubMed ID: 11137626 [TBL] [Abstract][Full Text] [Related]
6. Noradrenergic modulation of serotonin release in rat dorsal and median raphé nuclei via alpha(1) and alpha(2A) adrenoceptors. Hopwood SE; Stamford JA Neuropharmacology; 2001 Sep; 41(4):433-42. PubMed ID: 11543763 [TBL] [Abstract][Full Text] [Related]
8. Low concentrations of angiotensin II unmask vasoconstrictory alpha 2-adrenoceptors in isolated perfused kidneys of spontaneously hypertensive rats. Bohmann C; Rist W; Schollmeyer P; Rump LC Cardiovasc Res; 1995 Dec; 30(6):857-65. PubMed ID: 8746199 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the postjunctional alpha 2C-adrenoceptor mediating vasoconstriction to UK14304 in porcine pulmonary veins. Görnemann T; von Wenckstern H; Kleuser B; Villalón CM; Centurión D; Jähnichen S; Pertz HH Br J Pharmacol; 2007 May; 151(2):186-94. PubMed ID: 17375080 [TBL] [Abstract][Full Text] [Related]
10. Hypothalamic alpha 2A-adrenoceptors stimulate growth hormone release in the rat. Makara GB; Kiem DT; Vizi ES Eur J Pharmacol; 1995 Dec; 287(1):43-8. PubMed ID: 8666024 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of smooth muscle alpha adrenoceptors in rat tail artery in vitro. Medgett IC; Langer SZ J Pharmacol Exp Ther; 1984 Jun; 229(3):823-30. PubMed ID: 6144792 [TBL] [Abstract][Full Text] [Related]
12. Involvement of beta 2-adrenoceptor-mediated mechanisms in the cardiovascular responses to alpha 1- and alpha 2-adrenoceptor antagonism in conscious, unrestrained, Long Evans and Brattleboro rats. Gardiner SM; Bennett T Br J Pharmacol; 1988 Jan; 93(1):9-22. PubMed ID: 2894880 [TBL] [Abstract][Full Text] [Related]
13. Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat. McDaid J; Docherty JR Br J Pharmacol; 2001 Jun; 133(3):429-37. PubMed ID: 11375260 [TBL] [Abstract][Full Text] [Related]
14. Effect of desipramine on the effects of alpha-adrenoceptor inhibitors on pressor responses and release of norepinephrine into plasma of pithed rats. Zukowska-Grojec Z; Bayorh MA; Kopin IJ J Cardiovasc Pharmacol; 1983; 5(2):297-301. PubMed ID: 6188906 [TBL] [Abstract][Full Text] [Related]
16. Renal effects of infusion of rilmenidine and guanabenz in conscious dogs: contribution of peripheral and central nervous system alpha 2-adrenoceptors. Evans RG; Anderson WP Br J Pharmacol; 1995 Sep; 116(1):1557-70. PubMed ID: 8564219 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies. Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556 [TBL] [Abstract][Full Text] [Related]
18. In vivo pharmacological profile of SL 84.0418, a new selective, peripherally active alpha 2-adrenoceptor antagonist. Angel I; Grosset A; Perrault G; Schoemaker H; Langer SZ Eur J Pharmacol; 1993 Apr; 234(2-3):137-45. PubMed ID: 8097719 [TBL] [Abstract][Full Text] [Related]
19. Smooth muscle alpha-2 adrenoceptors mediate vasoconstrictor responses to exogenous norepinephrine and to sympathetic stimulation to a greater extent in spontaneously hypertensive than in Wistar Kyoto rat tail arteries. Medgett IC; Hicks PE; Langer SZ J Pharmacol Exp Ther; 1984 Oct; 231(1):159-65. PubMed ID: 6149302 [TBL] [Abstract][Full Text] [Related]
20. Failure of selective antagonists (CH-38083 and idazoxan) to distinguish between prejunctional and postjunctional alpha 2-adrenoreceptors. Lonart G; Harsing LG; Folly G; Vizi ES J Auton Pharmacol; 1989 Apr; 9(2):149-58. PubMed ID: 2565902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]